{
    "id": 3074,
    "name": "giant cell glioblastoma",
    "source": "DOID",
    "definition": "A glioblastoma multiforme that is characterized by a prevalence of bizarre, multinucleated giant cells. [url:http\\://en.wikipedia.org/wiki/Giant-cell_glioblastoma, url:http\\://neuro-oncology.oxfordjournals.org/content/11/6/833.full]",
    "currentPreferredTerm": null,
    "lastUpdateDateFromDO": "03/24/2020",
    "altIds": [
        
    ],
    "termId": "DOID:3074",
    "evidence": [
        
    ],
    "clinicalTrials": [
        {
            "nctId": "NCT01730950",
            "title": "Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma",
            "phase": "Phase II",
            "recruitment": "Active, not recruiting",
            "therapies": [
                {
                    "id": 667,
                    "therapyName": "Bevacizumab",
                    "synonyms": null
                }
            ]
        },
        {
            "nctId": "NCT02078648",
            "title": "Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme",
            "phase": "Phase Ib/II",
            "recruitment": "Completed",
            "therapies": [
                {
                    "id": 3010,
                    "therapyName": "SL-701",
                    "synonyms": null
                },
                {
                    "id": 2595,
                    "therapyName": "Poly ICLC",
                    "synonyms": null
                },
                {
                    "id": 667,
                    "therapyName": "Bevacizumab",
                    "synonyms": null
                }
            ]
        },
        {
            "nctId": "NCT02743078",
            "title": "Optune Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma",
            "phase": "Phase II",
            "recruitment": "Terminated",
            "therapies": [
                {
                    "id": 667,
                    "therapyName": "Bevacizumab",
                    "synonyms": null
                }
            ]
        }
    ]
}